{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:44:36Z","timestamp":1773085476256,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.remnie.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:51:32Z","timestamp":1669290692000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of 11C-choline PET\/CT in prostate cancer surveillance"],"prefix":"10.1016","volume":"42","author":[{"given":"I.","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Arcocha-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"G\u00f3mez-de la Fuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Salm\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mart\u00ednez-Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mendi-Barcina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Andr\u00e9s-Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guti\u00e9rrez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pombo-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bota-Bota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rodil-Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2022.11.005_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2967\/jnumed.115.170126","article-title":"Evaluation of prostate cancer with 11C-choline PET\/CT for treatment planning, response assessment, and prognosis","volume":"57","author":"Ceci","year":"2016","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2022.11.005_bib0010","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Prostate cancer. Versi\u00f3n 4.2022 [accessed 8 Jun 2022]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"10.1016\/j.remnie.2022.11.005_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNM.0000000000000040","article-title":"Meta-analysis of 11C-choline and 18F-choline PET\/CT for management of patients with prostate cancer","volume":"35","author":"von Eyben","year":"2014","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2022.11.005_bib0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Conford","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/21681805.2015.1005665","volume":"49","author":"Evangelista","year":"2015","journal-title":"Scand J Urol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0030","first-page":"284","article-title":"Diagnostic utility and therapeutic impact of PET\/CT 18F-fluoromethylcholine in the biochemical recurrence of prostate cancer","volume":"39","author":"S\u00e1nchez","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MNM.0000000000000936","article-title":"Effect of positive carbon-11-choline PET\/CT results in the therapeutic management of prostate cancer biochemical relapse","volume":"40","author":"G\u00f3mez-de la Fuente","year":"2019","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2022.11.005_bib0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00259-017-3866-2","article-title":"Prognostic value of 18F\u2013choline PET\/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide","volume":"45","author":"Caroli","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2022.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00259-016-3428-z","article-title":"11C-choline PET\/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series","volume":"43","author":"Graziani","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2022.11.005_bib0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MNM.0000000000001189","article-title":"18F-choline PET\/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies","volume":"41","author":"Jim\u00e9nez","year":"2020","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2022.11.005_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fonc.2020.00055","article-title":"Imaging for metastasis in prostate cancer: a review of the literature","volume":"10","author":"Turpin","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12094-018-1985-2","article-title":"Diagnostic performance of 18F-choline PET-CT in prostate cancer","volume":"21","author":"Samper","year":"2019","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0065","first-page":"437","article-title":"Usefulness of 18F-Choline Positron Emission Tomography - Computed Tomography in the therapeutic management of patients with biochemical recurrence of prostate adenocarcinoma treated with brachytherapy","volume":"44","author":"Lopez","year":"2020","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.remnie.2022.11.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.07.017","article-title":"\u201cReal-world\u201d evaluation of 18F-choline PET\/CT practices in prostate cancer patients and impact on changes in therapeutic strategy","volume":"38","author":"Niziers","year":"2020","journal-title":"Urol Oncol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0075","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00259-012-2083-2","article-title":"Clinical impact of 18F-choline PET\/CT in patients with recurrent prostate cancer","volume":"39","author":"Soyka","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2022.11.005_bib0080","first-page":"156","article-title":"Contribution of 11C-choline PET\/CT in prostate carcinoma biochemical relapse with serum PSA level below 1 ng\/ml","volume":"37","author":"G\u00f3mez-de la Fuente","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0085","first-page":"197","article-title":"Value of 18F-choline PET\/MRI hybrid technique on the therapeutic approach for patients with prostate cancer treated with prostatectomy and rising prostate specific antigen levels below 1\u202fng\/ml","volume":"39","author":"Garc\u00eda","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0090","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00259-018-4253-3","article-title":"11C-choline PET\/CT predicts survival in prostate cancer patients with PSA\u202f<\u202f1\u202fng\/ml","volume":"46","author":"Giovacchini","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2022.11.005_bib0095","first-page":"28","article-title":"Detection of second tumors in 11C-choline PET\/CT studies performed due to biochemical recurrence of prostate cancer","volume":"33","author":"Garc\u00eda","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.acuro.2016.09.015","article-title":"Molecular imaging for prostate cancer: performance analysis of 68Ga-PSMA PET\/CT versus choline PET\/CT","volume":"41","author":"Michaud","year":"2017","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.remnie.2022.11.005_bib0105","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3390\/cancers14071770","article-title":"PSMA and Choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature","volume":"14","author":"Alongi","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.remnie.2022.11.005_bib0110","first-page":"126","article-title":"The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma","volume":"41","author":"Rodr\u00edguez-Fraile","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.remnie.2022.11.005_bib0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/cancers11050710","article-title":"Detection rate of 18F-labeled PSMA PET\/CT in biochemical recurrent prostate cancer: a systematic review and a meta-analysis","volume":"11","author":"Treglia","year":"2019","journal-title":"Cancers."},{"key":"10.1016\/j.remnie.2022.11.005_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5603\/NMR.2015.0015","article-title":"The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer \u2013 a prospective observational study","volume":"18","author":"Golubi\u0107","year":"2015","journal-title":"Nucl Med Rev Cent East Eur."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:24Z","timestamp":1762418724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808922001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2253808922001112"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2022.11.005","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of 11C-choline PET\/CT in prostate cancer surveillance","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2022.10.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}